참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | 4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid | HCID 23831 | — |
| 반응물 | crotonoyl-CoA | HCID 5497143 | — |
| 반응물 | Nadh nad+ | HCID 86639099 | — |
| 용매 | Dimethyl Sulfoxide | HCID 679 | — |
| 생성물 | Nadide (JAN/USAN/INN) | HCID 5893 | — |
| 생성물 | Nadh | HCID 439153 | — |
| 생성물 | crotonoyl-CoA | HCID 5497143 | — |
반응 단계
The assay buffer “AB” contains 50 mM Hepes pH7.5, 100 μM Dithiothreitol, 0.006% Triton-X100. The following components are added in a black polystyrene Costar plate up to a final volume of 55 μL: 1.5 μL DMSO, or inhibitor dissolved in DMSO and 53.5 μL of a FabI/NADH/NAD+ mixture in AB. After 60 min of pre-incubation at room temperature, the reaction is started by addition of 5 μL of Crotonoyl-CoA to a final volume of 60 μL. This reaction mixture is then composed of 40 nM FabI (produced in house from E. coli, C-terminal 6-His tagged), 20 μM NADH (Biochemika), 10 μM NAD+ (Biochemika), 50 μM Crotonoyl-CoA (Biochemika) and compound at defined concentration. Fluorescence intensity of NADH (lex=360 nm, lem=520 nm) is measured immediately after Crotonoyl-CoA addition, and 2 hours later by a Fluostar Optima (BMG). Enzyme activity is proportional to the signal decrease from which inhibition percentages are derived. For IC50 determinations, the inhibitor is tested at 6 to 10 different concentrations, and the related inhibitions are fitted to a classical langmuir equilibrium model using XLFIT (IDBS).
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US09309179B2 |
|---|
| 출처 데이터셋 | uspto-grants-2016_04 |
|---|
| ORD ID | ord-52bd2822a5454a239c69c54faf56b86d |
|---|
| 출처 메모 | uspto-grants-2016_04 |
|---|